Saprisartan: Antihypertensive angiotensin II receptor antagonist

Drugs of the Future

Volumn 21, Issue 11, 1996, Pages 1129-1135

  Robinson, K A ^a   Robinson, C P ^a   Castaner J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; ENALAPRIL; HYDRALAZINE; RECEPTOR SUBTYPE; SAPRISARTAN;

BIOAVAILABILITY; BLOOD PRESSURE; DOG; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HEMODYNAMICS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; KIDNEY FUNCTION; LIVER; NONHUMAN; ORAL DRUG ADMINISTRATION; REACTION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY;

EID: 0030482325     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.11.380762     Document Type: Article

References (23)

1. Judd, D.B., Dowle, M.D., Middlemiss, D. et al. Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability. J Med Chem 1994, 37(19): 3108-20.
2. Ross, B.C., Middlemiss, D., Scopes, D.I.C. et al. (Glaxo Group, Ltd.). 1H-Imidazol-1-yl-methyl benzofuran derivs. with the imidazolyl moiety being substd. by a cycloalkyl group. EP 514198, JP 94211846, US 5498722, WO 9220674.
3. Carr, R.M., Cable, K.M., Newman, J.J., Sutherland, D.R. Synthesis of isotopically labelled angiotensin II antagonist GR138950X. J Label Compound Radiopharm 1996, 38: 453.
4. Tsunoda, K., Abe, K., Hagino, T., Omata, K., Misawa, S., Imai, Y., Yoshinga, K. Hypotensive effects of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension. Amer J Hypertension 1993, 6: 28-32.
5. Dostal, D.E., Baker, K.M. Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts. Trends Cardiovasc Med 1993, 3: 67-74.
6. Fuller, R.W., Warren, J.B., McCusker, M., Dollery, C.T. Effects of enalapril on the skin response to bradykinin in man. Brit J Pharmacol 1987, 23: 88-90.
7. Skidgel, R.A., Erdos, E.G. The broad substrate specificity of human angiotensin I converting enzyme. Clin Exp Hypertension 1987, A9: 243-59.
8. Chin, H.L., Buchan, D.A. Severe angioedema after long term use of an angiotensin converting enzyme inhibitor. Ann Intern Med 1990, 112: 312-3.
9. McEwan, J.R., Fuller, R.W. Angiotensin converting enzyme inhibitors and cough. J Cardiovasc Pharmacol 1989, 13(Suppl. 3): S67-9.
10. Hodges, J.C., Hamby, J.M., Blankley, C.J. Angiotensin II receptor binding inhibitors. Drugs Fut 1992, 17: 575-93.
11. Bovy, P.P., Trapani, A.J., McMahan, E.G., Palmono, M.A. Carboxy-terminus truncated analogue of angiotensin II[SAR1]-angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists. J Med Chem 1989, 32: 520-2.
12. Dowle, M.D., Judd, D.B., Middlemiss, D., Scopes, D.I.C. Benzofuran based angiotensin II antagonists related to GR11729: Part III: GR138950, a triflamide with high oral bioavailability. Bioorg Med Chem Lett 1993, 3: 2047-50.
13. Hilditch, A., Hunt, A.A.E., Travers, A. et al. Pharmacology of GR138950, a novel angiotensin AT1 receptor antagonist. Brit J Pharmacol 1993, 108(Suppl.): Abst 239P.
14. Guyton, A.C., Hall, J.E., Jackson, T.E. The basic kidney-blood volume-pressure regulatory system - The pressure diuresis and natriuresis phenomenon. In: Circulatory Physiology III, Arterial Pressure and Hypertension, A.C. Guyton (Ed.), W.B. Saunders Co., Philadelphia, 87P.
15. Navar, L.G., Saccomani, G., Mitchell, K.D. Synergistic intrarenal actions of angiotensin on tubular reabsorption and renal hemodynamics. Amer J Hypertens 1991, 4: 90.
16. 1 receptor antagonist. Eur J Pharmacol 1995, 280: 195-203.
17. 1 receptor antagonist. J Pharmacol Exp Ther 1995, 272: 750-7.
18. Kenakin, T.P. The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev 1984, 36: 165-222.
19. 1 receptor antagonist, GR138950. Brit J Pharmacol 1995, 115(Suppl.): Abst 56P.
20. 1 receptor antagonist GR138950. Brit J Pharmacol 1996, 118: 711-9.
21. 1 receptor antagonists, GR138950 and losartan, with enalapril in conscious renal hypertensive rats. Brit J Pharmacol 1994, 112(Suppl.): Abst 44P.
22. ω-nitro-L-arginine methyl ester in conscious renal hypertensive rats. Brit J Pharmacol 1995, 114(Suppl.):Abst 172P.
23. 1 receptor-mediated dipsogenic responses and in a brain ex vivo binding assay in the rat. Brit J Pharmacol 1993, 108(Suppl.): Abst 284P.